Express News | Watching Regulus Therapeutics; Shares See Volume To The Upside As Traders Circulate TipRanks Article Titled 'These 2 'Strong Buy' Penny Stocks Could Rally Over 500%, Say Analysts'

BenzingaOct 28 11:22 ET

Ventyx Biosciences' Tamuzimod: Promising Data but Insufficient for Upgrade Beyond Hold

TipRanksOct 15 11:45 ET · Ratings

Express News | Ventyx Biosciences Presents New 52-Week Results From the Phase 2 Trial of Vtx002 (Tamuzimod) in Ulcerative Colitis at Ueg Week 2024

ReutersOct 15 08:00 ET

Ventyx Biosciences Presents New 52-Week Results From the Phase 2 Trial of VTX002 (Tamuzimod) in Ulcerative Colitis at UEG Week 2024

GlobeNewswireOct 15 08:00 ET

Oppenheimer Maintains Ventyx Biosciences(VTYX.US) With Buy Rating, Maintains Target Price $10

Moomoo NewsSep 24 08:31 ET · Ratings

LifeSci Capital Maintains Ventyx Biosciences(VTYX.US) With Buy Rating

Moomoo NewsSep 23 22:31 ET · Ratings